Pricing Log in Create free account

InMed Pharmaceuticals Inc. (INM) vs Optimi Health Corp. (OPTH)

InMed Pharmaceuticals Inc. and Optimi Health Corp. are both Drug Manufacturers Specialty & Generic companies. Optimi Health Corp. is the larger, with a market value of $13.7M against $7.3M — 1.9× the size. Across the 5 metrics below, InMed Pharmaceuticals Inc. leads on 4 and Optimi Health Corp. on 1.

Valuation

Metric INM OPTH Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 15.78 n/m 2.08
P/B n/m 2.86 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 15.54 n/m 2.87
Earnings yield (23.08%) — (15.94%)
Free cash flow yield (11.11%) (66.34%) 0.00%

Profitability

Metric INM OPTH Drug Manufacturers Specialty & Generic median
Gross margin 33.62% — 53.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (261.69%) — (0.80%)
Return on assets (185.40%) — (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INM OPTH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (6.73%) — 5.22%
EPS growth (last fiscal year) 62.68% (1,575.96%) 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INM OPTH Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 1.02 0.04
Current ratio 0.50 0.06 2.41
Net debt to EBITDA 0.20 (0.67) 1.01

Dividend

Metric INM OPTH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric INM OPTH Drug Manufacturers Specialty & Generic median
Market cap 7.26m 13.69m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack